Depression Patients Treated with Psychedelic Mushrooms 5 years ago Are Still ‘Symptom-Free’

The study involved participants from a trial published in 2021 that found psilocybin—the primary psychedelic substance produced by mushrooms. Read More

Psychedelic drug popular in 1960s could ease anxiety as doctors share warnings

A new study shows that LSD reduced anxiety symptoms in adults with generalized anxiety disorder, with 100-microgram doses proving most effective in a clinical trial. Read More

Single psilocybin trip delivers two years of depression relief for cancer patients

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy ... Read More

Single dose of 'magic mushrooms' provides 5 years of depression relief, researchers find

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at ... Read More

Just one single dose of ‘magic mushrooms’ could relieve depression for 5 years, researchers find

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at ... Read More

Psychedelics For New Moms? All About The Unexpected New Study That Could Transform Postpartum Care

A few days before Nohea gave birth to her second baby, in 2016, the now 40-year-old from Texas had a strong sense of foreboding. She’d struggled through severe postpartum depression (PPD) with her ... Read More

Compass’ psychedelic drug to treat depression meets goal in trial

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a late-stage trial. The company said its psilocybin drug reduced depression ... Read More

LSD Microdosing Could Be Key to Easing Anxiety

This study is a true turning point.' ... Read More

AbbVie targets psychedelic-based depression drug market with $1.2 billion deal

AbbVie will buy an experimental depression drug from partner Gilgamesh ... which is also developing treatments for anxiety and post-traumatic stress disorder, also launch AbbVie into the race to ... Read More

LSD shows promise for reducing anxiety in drugmaker’s midstage study

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has ... the ... Read More

Two years on from Australia's bold psychedelic experiment, here are our concerns

A small Australian trial that used psychedelic-assisted therapy to improve the mental health and well-being of terminally ill patients is in the news today. The results are based on research conducted ... Read More